Progressing vision to expand the reach of targeted radiopharmaceuticals to large patient populations Anticipating multiple milestones in the next 12 months, including initiation of Phase 1b clinical ...
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show ...
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, ...
Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...
Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced today that it has received clearance from the Center for Drug ...
Company continues to evaluate strategic options to maximize shareholder valueWATERTOWN, Mass., March 27, 2026 (GLOBE NEWSWIRE ...
Sleeping sickness is a notorious disease — immortalized in Joseph Conrad's Heart of Darkness. A single bite from a tsetse fly carrying the parasite is all it takes to infect someone. Without treatment ...
Bayer BAYRY’s wholly owned subsidiary, AskBio Inc., announced the completion of patient enrollment in the mid-stage GenePHIT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results